ASTM E2363-05b - 15.10.2005
 
1. Scope

1.1 This terminology covers process analytical technology in the pharmaceutical industry. Terms are defined as they are used relative to the PAT framework in the pharmaceutical industry. Terms that are generally understood and in common usage or adequately defined in other readily available references are not included except where particular delineation to process analytical technology may be more clearly stated.

1.2 This terminology is therefore intended to be selective of terms used generally in process analytical technology as it is applied in the pharmaceutical industry and published in a number of documents, such as those listed in the succeeding sections. The listing is also intended to define terms that appear prominently within other related ASTM standards and do not appear elsewhere.

1.3 The definitions are substantially identical to those published by the U.S. Food and Drug Administration and other authoritative bodies, such as ISO, IEC, ITU, and national standards organizations.

1.4 This terminology supplements current documents on terminology that concentrate on process analytical technology as it is applied in the pharmaceutical industry.

1.5 An increasing number of product designations and designations for chemical, physical, mechanical, analytical, and statistical tests and standards are coming into common usage in the literature, regulatory environment, and commerce associated with process analytical technology in the pharmaceutical industry. Section 2 lists those documents referenced in this terminology.

 
2. Referenced Documents

ICH Q7

Guidance for Industry--Good Manufacturing Practice Guide For Active Pharmaceutical Ingredients

ICH Q8 (R2)

Guidance for Industry--Pharmaceutical Development

ICH Q9

Guidance for Industry--Quality Risk Management

ICH Q10

Guidance for Industry--Pharmaceutical Quality System

ICH Q11

Guidance for Industry--Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities)

ISO?9000:2005

Quality Management Systems--Fundamentals and Vocabulary

ISO?EN?14971:2012

Medical Devices--Application of Risk Management for Medical Devices

ISO/IEC Guide 51:2014

Safety Aspects--Guidelines for Their Inclusion in Standards

ISO Guide 73:2009

Risk Management--Vocabulary

EU GMP Glossary

21?CFR?314.3(b)

Applications for FDA Approval to Market a New Drug--General Provisions--Definitions

ICH R2 (Q1)

Validation of Analytical Procedures: Text and Methodology

ICH Q6A

Guidance for Industry--Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances

ICH Q6B

Guidance for Industry--Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products

21?CFR ?210.3(b)

Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; General--Definitions